Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 3/20 | 0.37 |
| ▸ | ACHE | P22303 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | HPGD | P15428 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8976156 | 0.91 | ACHE (0.43) | BCHEACHEMAPTKDM4EALDH1A1 | |
| SCHEMBL8976154 | 0.75 | MAPT (0.33) | BCHEACHEMAPTKDM4EALDH1A1 | |
| Trifluoromethanesulfonic Acid SCHEMBL8976223 | 0.70 | ACHE (0.50) | BCHEACHEMAPT | |
| SCHEMBL8975983 | 0.69 | MAOA (0.43) | ACHEMAPTKDM4EALDH1A1HPGD | |
| SCHEMBL8976111 | 0.68 | ADORA3 (0.43) | BCHEACHEMAPTKDM4EALDH1A1 | |
| Trifluoromethanesulfonic Acid SCHEMBL8976067 | 0.65 | NSD2 (0.34) | — | |
| SCHEMBL2718491 | 0.64 | ACHE (0.40) | BCHEACHEMAPTKDM4EALDH1A1 | |
| Trifluoromethanesulfonic Acid SCHEMBL8976385 | 0.64 | — | — | |
| SCHEMBL11435867 | 0.61 | POLB (0.37) | MAPTMEN1KMT2A | |
| SCHEMBL8975796 | 0.60 | DDB1 (0.34) | MAPTKDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5532261-A | TREATING STAPHYLOCOCCUS INFECTIONS | MERCK & CO., INC. (US) | 1996-07-02 | — | — | US | disclosed |